MedRes opens medical device technology center in Carlsbad, CA [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
in Carlsbad, California , in May 2024 . The Carlsbad site is equipped to accelerate customer projects in the fields of cardiovascular intervention and minimally invasive surgery. The Carlsbad team specializes in design, computational simulation, rapid prototype iteration, development, testing, and characterization of medical devices, particularly those enabled by the unique properties of Nitinol, and requiring high performance custom delivery systems. Together with our established research, development and production capabilities in Budapest , MedRes now offers its customers access to world class medical research and engineering services, and direct engagement with experienced industry veterans. The MedRes team in Carlsbad is led by Chief Operating Officer Christine Trepanier . With over 25 years of experience in the development and manufacturing of medical devices, Christine is responsible for operations and new product development at MedRes. Prior to this position, she held roles
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M [Yahoo! Finance]Yahoo! Finance
- How Much Money Can I Get From The Hair Relaxer Lawsuit? [Forbes]Forbes
- Best Los Angeles Mesothelioma Lawyers Of 2024 [Forbes]Forbes
- Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $175.00 price target on the stock.MarketBeat
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/16/24 - Form 424B2
- 5/15/24 - Form 424B2
- 5/14/24 - Form FWP
- JNJ's page on the SEC website